The Zeste Homolog 2 Enhancer (EZH2) can be activated by certain inflammatory factors within the tumor microenvironment in a manner dependent on NF-κB, and the expression of ER was significantly increased following the silencing of EZH2 (102). Here, NFKB1 is linked to neoplasm.